{"title":"动脉瘤夹闭术后动脉瘤性蛛网膜下腔出血患者血清上下垂铁标志物水平及临床意义。","authors":"Xiaoli Wu, Xiqi Hu, Ying Xia, Bo Wang","doi":"10.1016/j.jstrokecerebrovasdis.2025.108440","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to explore the association between ferroptosis markers and postoperative prognosis in patients with aneurysmal subarachnoid hemorrhage (aSAH) who underwent aneurysm clipping. Specifically, we evaluated the predictive value of ferroptosis markers in determining post-operative outcomes.</div></div><div><h3>Methods</h3><div>We conducted a prospective observational study involving 210 aSAH patients who underwent aneurysm clipping surgery at our institution from October 2021 to May 2023. Blood samples were collected at postoperative days 1, 3, 7, and 30 to assess the levels of ferroptosis markers (ACSL4, SLC7A11, GPX4) and inflammatory cytokines (CRP, IL-6, TNF-α) using enzyme-linked immunosorbent assay (ELISA). Clinical data were recorded at baseline. Postoperative prognosis was assessed using the modified Rankin Scale (mRS) at 30 days post-surgery. All patients included in the study underwent aneurysm clipping surgery as their primary treatment modality.</div></div><div><h3>Results</h3><div>The serum levels of ACSL4 and IL-6 were significantly higher in the mRS 3-6 group compared to the mRS 0-2 group at all time points. In contrast, SLC7A11 and GPX4 levels were significantly lower in the mRS 3-6 group. Spearman’s correlation analysis revealed a significant negative correlation between ACSL4 and GPX4 and a positive correlation between ACSL4 and IL-6 levels. ROC curve analysis demonstrated that ACSL4 had the highest predictive value for poor postoperative prognosis, with an area under the curve (AUC) of 0.757. Multivariate logistic regression analysis identified aneurysm size, GCS, SLC7A11, ACSL4, GPX4, and IL-6 as independent risk factors for poor postoperative prognosis.</div></div><div><h3>Conclusion</h3><div>Serum ferroptosis markers, particularly ACSL4, along with inflammatory markers, have significant potential in predicting the postoperative prognosis of aSAH patients. These markers could serve as useful biomarkers for early risk stratification and clinical decision-making in aSAH management.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 11","pages":"Article 108440"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The serum levels and clinical significance of ferroptosis markers in patients with aneurysmal subarachnoid hemorrhage who underwent aneurysm clipping surgery\",\"authors\":\"Xiaoli Wu, Xiqi Hu, Ying Xia, Bo Wang\",\"doi\":\"10.1016/j.jstrokecerebrovasdis.2025.108440\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>This study aimed to explore the association between ferroptosis markers and postoperative prognosis in patients with aneurysmal subarachnoid hemorrhage (aSAH) who underwent aneurysm clipping. Specifically, we evaluated the predictive value of ferroptosis markers in determining post-operative outcomes.</div></div><div><h3>Methods</h3><div>We conducted a prospective observational study involving 210 aSAH patients who underwent aneurysm clipping surgery at our institution from October 2021 to May 2023. Blood samples were collected at postoperative days 1, 3, 7, and 30 to assess the levels of ferroptosis markers (ACSL4, SLC7A11, GPX4) and inflammatory cytokines (CRP, IL-6, TNF-α) using enzyme-linked immunosorbent assay (ELISA). Clinical data were recorded at baseline. Postoperative prognosis was assessed using the modified Rankin Scale (mRS) at 30 days post-surgery. All patients included in the study underwent aneurysm clipping surgery as their primary treatment modality.</div></div><div><h3>Results</h3><div>The serum levels of ACSL4 and IL-6 were significantly higher in the mRS 3-6 group compared to the mRS 0-2 group at all time points. In contrast, SLC7A11 and GPX4 levels were significantly lower in the mRS 3-6 group. Spearman’s correlation analysis revealed a significant negative correlation between ACSL4 and GPX4 and a positive correlation between ACSL4 and IL-6 levels. ROC curve analysis demonstrated that ACSL4 had the highest predictive value for poor postoperative prognosis, with an area under the curve (AUC) of 0.757. Multivariate logistic regression analysis identified aneurysm size, GCS, SLC7A11, ACSL4, GPX4, and IL-6 as independent risk factors for poor postoperative prognosis.</div></div><div><h3>Conclusion</h3><div>Serum ferroptosis markers, particularly ACSL4, along with inflammatory markers, have significant potential in predicting the postoperative prognosis of aSAH patients. These markers could serve as useful biomarkers for early risk stratification and clinical decision-making in aSAH management.</div></div>\",\"PeriodicalId\":54368,\"journal\":{\"name\":\"Journal of Stroke & Cerebrovascular Diseases\",\"volume\":\"34 11\",\"pages\":\"Article 108440\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-08-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Stroke & Cerebrovascular Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1052305725002174\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305725002174","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
The serum levels and clinical significance of ferroptosis markers in patients with aneurysmal subarachnoid hemorrhage who underwent aneurysm clipping surgery
Objective
This study aimed to explore the association between ferroptosis markers and postoperative prognosis in patients with aneurysmal subarachnoid hemorrhage (aSAH) who underwent aneurysm clipping. Specifically, we evaluated the predictive value of ferroptosis markers in determining post-operative outcomes.
Methods
We conducted a prospective observational study involving 210 aSAH patients who underwent aneurysm clipping surgery at our institution from October 2021 to May 2023. Blood samples were collected at postoperative days 1, 3, 7, and 30 to assess the levels of ferroptosis markers (ACSL4, SLC7A11, GPX4) and inflammatory cytokines (CRP, IL-6, TNF-α) using enzyme-linked immunosorbent assay (ELISA). Clinical data were recorded at baseline. Postoperative prognosis was assessed using the modified Rankin Scale (mRS) at 30 days post-surgery. All patients included in the study underwent aneurysm clipping surgery as their primary treatment modality.
Results
The serum levels of ACSL4 and IL-6 were significantly higher in the mRS 3-6 group compared to the mRS 0-2 group at all time points. In contrast, SLC7A11 and GPX4 levels were significantly lower in the mRS 3-6 group. Spearman’s correlation analysis revealed a significant negative correlation between ACSL4 and GPX4 and a positive correlation between ACSL4 and IL-6 levels. ROC curve analysis demonstrated that ACSL4 had the highest predictive value for poor postoperative prognosis, with an area under the curve (AUC) of 0.757. Multivariate logistic regression analysis identified aneurysm size, GCS, SLC7A11, ACSL4, GPX4, and IL-6 as independent risk factors for poor postoperative prognosis.
Conclusion
Serum ferroptosis markers, particularly ACSL4, along with inflammatory markers, have significant potential in predicting the postoperative prognosis of aSAH patients. These markers could serve as useful biomarkers for early risk stratification and clinical decision-making in aSAH management.
期刊介绍:
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.